Skip to main content

Table 1 Age, gender, disease duration, smoking habit and clinical characteristics of subjects according to therapy

From: Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy

 

Empagliflozin group

Control group

Number

20

15

Age (years)

58 ± 9

60 ± 7

Males (%)

75

80

Disease duration (years)

15 ± 9

17 ± 10

Obesity (%)

50

40

Hypertension (%)

93

100

Hyperlipidemia (%)

90

93

Smoking habit (%)

30

33

  1. Data are expressed as the mean ± SD or percentage
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840